India set to mandate coding of all drugs to curb fakes
This article was originally published in Scrip
India is planning to take additional steps to curb the menace of spurious and counterfeit drugs in the country. A proposal to make it mandatory to include a 2D bar code and a unique identifier code on all medicine packs in India has been cleared by the Drugs Consultative Committee, which falls under the ministry of health and family welfare. The proposal, according to local media reports, will be considered by India's Drug Technical Advisory Board, reports in the local media said.
You may also be interested in...
Indian drug makers appear confident of meeting both domestic and global requirements for hydroxychloroquine sulphate after India relaxed export curbs on the product, subject to strict monitoring, against the backdrop of requests from global heads of government for supplies of the potential treatment for COVID-19.
The termination of the Aurobindo-Sandoz deal isn’t perhaps all bad news for the Indian firm and the flip side may be an improved balance sheet, according to some analysts. But the resolution of compliance issues at manufacturing facilities remains critical.
Aurobindo and Sandoz mutually terminate their planned $1bn deal, leaving many questions on how both sides will re-orient strategies going forward.